SCHEMBL6288468

SCHEMBL6288468

Nc1ccc2nc3cc[nH]n3c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.41
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
RXFP1 Q9HBX9 2/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
MAPT P10636 7/20 0.38
KDM4E B2RXH2 7/20 0.38
GAA P10253 4/20 0.38
ALDH1A1 P00352 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
GLA P06280 3/20 0.38
NPC1 O15118 2/20 0.38
RECQL P46063 2/20 0.38
RAB9A P51151 2/20 0.38
GFER P55789 2/20 0.38
DYRK1A Q13627 1/20 0.37
PLAU P00749 1/20 0.36
POLB P06746 4/20 0.36
PKM P14618 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2272346 0.86 KDM4E (0.41) LOXL2MEN1KMT2AMAPTKDM4E
SCHEMBL2270638 0.82 LOXL2 (0.41) LOXL2MEN1KMT2ACACNA1BAPBA1
SCHEMBL6286886 0.72 ALDH1A1 (0.37) LOXL2KMT2AMAPTKDM4EGAA
SCHEMBL2270590 0.71 RAD51 (0.39) LOXL2MEN1KMT2AMAPTKDM4E
SCHEMBL6288044 0.70 MAPT (0.39) LOXL2MEN1KMT2AMAPTKDM4E
SCHEMBL33680 0.70 RAD51 (0.48) LOXL2MEN1KMT2AKDM4ENPC1
SCHEMBL2267039 0.67 MEN1 (0.43) LOXL2MEN1KMT2AKDM4EPKM
SCHEMBL31690247 0.67 KDM4E (0.66) MEN1KMT2AMAPTKDM4EGAA
SCHEMBL2267410 0.66 HTT (0.48) SMN1; SMN2HTTHPGDTDP1HSD17B10
SCHEMBL832572 0.65 KDM4E (0.40) MEN1KMT2ARXFP1CACNA1BAPBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923929-B1 KERATIN FIBRE DYE COMPOSITION CONTAINING PYRAZOLO-AZOLE COMPOUNDS, USE THEREOF AS OXIDATION AGENTS, AND DYEING METHOD; PYRAZOLOAZOLES OREAL (FR) 2004-05-12 EP claimed
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'OREAL 2002-10-24 US claimed
US-6379397-B2 CAPABLE OF GENERATING INTENSE COLORINGS IN VARIED SHADES L'OREAL S.A. (FR) 2002-04-30 US claimed
US-6855827-B2 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'ORÉAL (FR) 2005-02-15 US disclosed
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles L'OREAL 2002-10-24 US disclosed
US-6379397-B2 CAPABLE OF GENERATING INTENSE COLORINGS IN VARIED SHADES L'OREAL S.A. (FR) 2002-04-30 US disclosed
US-20020007520-A1 COMPOSITIONS FOR DYEING KERATINOUS FIBERS COMPRISING PYRAZOLOAZOLES; THEIR USE IN DYEING AS OXIDATION BASE AND DYEING PROCESS; AND NOVEL PYRAZOLOAZOLES L'OREAL S.A. (FR) 2002-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007520-A1 COMPOSITIONS FOR DYEING KERATINOUS FIBERS COMPRISING PYRAZOLOAZOLES; THEIR USE IN DYEING AS OXIDATION BASE AND DYEING PROCESS; AND NOVEL PYRAZOLOAZOLES KRT18, ZYX, TUBB3 LOXL2 2947/4885MEN1 4719/4885KMT2A 1852/4885
US-20020152558-A1 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles KRT18, ZYX, TUBB3 LOXL2 2947/4885MEN1 4719/4885KMT2A 1852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.